Please login to the form below

Not currently logged in
Email:
Password:

Oragenics

This page shows the latest Oragenics news and features for those working in and with pharma, biotech and healthcare.

Meeting with resistance

Oragenics believes that large-scale, cost-effective production of clinical grade MU1140-S will be possible by use of DPOLTTM. ... It appears unlikely that NAI-107 is as far advanced in development as Oragenics' MU1140-S.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Alan Joslyn becomes president and CEO of Oragenics Dr Alan Joslyn becomes president and CEO of Oragenics

    Dr Alan Joslyn becomes president and CEO of Oragenics. He will also serve on the company’ s board of directors. ... Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board of directors.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics